Salicylates
Salicylates are a family of organic compounds derived from salicylic acid (2-hydroxybenzoic acid). They occur naturally in many plants as a defense chemical and are the basis of aspirin (acetylsalicylic acid). Their interaction with Mast Cells occurs through a completely different pathway than Histamine — primarily through the Arachidonic Acid metabolism system.
Chemistry
Salicylic acid has a benzene ring with a hydroxyl group and a carboxylic acid group. Plants produce it as part of their immune defense — it signals systemic acquired resistance (the plant equivalent of an immune response). Structurally related compounds (methyl salicylate, acetylsalicylate, etc.) are collectively called salicylates.
They’re present in many fruits, vegetables, herbs, and spices — often the same foods that appear on histamine liberator lists. Concentrations are highest in unripe fruit and decrease with ripening.
The COX Pathway Connection
Here’s where the biochemistry gets specific.
COX Enzymes (cyclooxygenase-1 and -2) convert Arachidonic Acid into prostaglandins and thromboxanes. This is one of two major pathways for processing arachidonic acid (the other being the 5-LOX pathway that produces Leukotrienes).
Salicylates inhibit COX enzymes. This is how aspirin works as a pain reliever and anti-inflammatory — it blocks prostaglandin production.
The problem: when COX is inhibited, more arachidonic acid gets shunted through the 5-LOX pathway instead. This increases leukotriene production. In people with mast cell conditions:
- Increased LTC4/LTD4/LTE4 production → bronchoconstriction, vasodilation, mucus production
- Cysteinyl leukotrienes can directly activate mast cells, triggering further Degranulation
- The net effect can be worse than the baseline — you’ve traded one set of mediators for a more potent set
This is the mechanism behind aspirin-exacerbated respiratory disease (AERD, formerly Samter’s triad) and explains why many MCAS patients are salicylate-sensitive.
Dietary Salicylates vs. Pharmaceutical
Pharmaceutical doses (aspirin: 325-650mg acetylsalicylate) produce strong COX inhibition. The effect is pharmacologically significant and well-characterized.
Dietary doses from food are much lower, and the evidence for dietary salicylate sensitivity is more contested. Some researchers argue that the amounts in food are too low to produce meaningful COX inhibition. Others point to the cumulative effect of dietary salicylates in people whose mast cells are already primed — the Total Mediator Load framework suggests that even small inputs matter when you’re near threshold.
State of the evidence
Pharmaceutical salicylate sensitivity in mast cell patients is well-established. Dietary salicylate sensitivity as a distinct clinical entity is more controversial. It’s plausible biochemically, many patients report clear symptom correlation, but high-quality controlled studies are limited. This is an area where clinical experience outpaces formal evidence. The variability in salicylate content across plant varieties and growing conditions further complicates this — see Food Science Kit for a measurement-based approach.
High-Salicylate Foods
Berries, tomatoes, peppers, many spices (especially turmeric, cumin, curry powder), mint, olive oil, coconut oil, honey, tea, wine, and most fruit juices. The overlap with Histamine Liberators lists is substantial, which makes it difficult to tease apart which mechanism is driving symptoms for a given individual without careful elimination and reintroduction. The Sensitivity Categories note maps multi-category overlap for common foods.
Implications for Management
- Montelukast (a leukotriene receptor antagonist) may be particularly helpful for people who are salicylate-sensitive, because it blocks the downstream effects of the pathway that salicylates amplify
- Avoiding NSAIDs is standard advice in MCAS, and the arachidonic acid shunting mechanism is the primary reason
- Dietary salicylate restriction is sometimes tried as part of an elimination approach, but it’s restrictive and should be weighed against nutritional adequacy